Literature DB >> 19439451

The end of lymphatic filariasis?

Moses J Bockarie1, David H Molyneux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19439451     DOI： 10.1136/bmj.b1686

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

1.  Preventive chemotherapy in human helminthiasis: theoretical and operational aspects.

Authors:  A-F Gabrielli; A Montresor; L Chitsulo; D Engels; L Savioli
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-10-29       Impact factor: 2.184

2.  The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Authors:  Brian K Chu; Pamela J Hooper; Mark H Bradley; Deborah A McFarland; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

3.  Lymphatic filariasis among the Yakurr people of Cross River State, Nigeria.

Authors:  Cletus I Iboh; Okpok E Okon; Kenneth N Opara; Joseph E Asor; Susan E Etim
Journal:  Parasit Vectors       Date:  2012-09-19       Impact factor: 3.876

4.  Nigeria Anopheles vector database: an overview of 100 years' research.

Authors:  Patricia Nkem Okorie; F Ellis McKenzie; Olusegun George Ademowo; Moses Bockarie; Louise Kelly-Hope
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

5.  Lymphatic filariasis mapping by immunochromatographic test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone.

Authors:  Joseph B Koroma; Momodu M Bangura; Mary H Hodges; Mohamed S Bah; Yaobi Zhang; Moses J Bockarie
Journal:  Parasit Vectors       Date:  2012-01-11       Impact factor: 3.876

6.  Increasing coverage in mass drug administration for lymphatic filariasis elimination in an urban setting: a study of Malindi Town, Kenya.

Authors:  Doris W Njomo; Dunstan A Mukoko; Nipher K Nyamongo; Joan Karanja
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

Review 7.  Diversity and transmission competence in lymphatic filariasis vectors in West Africa, and the implications for accelerated elimination of Anopheles-transmitted filariasis.

Authors:  Dziedzom K de Souza; Benjamin Koudou; Louise A Kelly-Hope; Michael D Wilson; Moses J Bockarie; Daniel A Boakye
Journal:  Parasit Vectors       Date:  2012-11-14       Impact factor: 3.876

8.  The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.

Authors:  Doris W Njomo; Mary Amuyunzu-Nyamongo; Japheth K Magambo; Sammy M Njenga
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

9.  The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014).

Authors:  Hugo C Turner; Alison A Bettis; Brian K Chu; Deborah A McFarland; Pamela J Hooper; Eric A Ottesen; Mark H Bradley
Journal:  Infect Dis Poverty       Date:  2016-05-24       Impact factor: 4.520

10.  The global distribution and transmission limits of lymphatic filariasis: past and present.

Authors:  Jorge Cano; Maria P Rebollo; Nick Golding; Rachel L Pullan; Thomas Crellen; Anna Soler; Louise A Kelly-Hope; Steve W Lindsay; Simon I Hay; Moses J Bockarie; Simon J Brooker
Journal:  Parasit Vectors       Date:  2014-10-11       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.